Article
Optimal therapy in genotype 4 chronic hepatitis C: finally cured?
Liver international : official journal of the International Association for the Study of the Liver - 1 Jan 2015
Abdel-Razek Wael, Waked Imam
Abstract excerpt
Optimal therapy for patients with hepatitis C virus (HCV) genotype 4 (HCV-4) infection is changing rapidly, and the possibility of a total cure is near. The standard of care has been combination pegylated interferon (PEG-IFN)-ribavirin (RBV), with modest response rates and considerable adverse events. Since the introduction of sofosbuvir (SOF), simeprevir (SIM), and daclatasvir (DCV), the duration of treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
